Telix Pharmaceuticals Limited
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TLX.AX | LGND | 1875.HK | NRIX | IDYA | 9995.HK | |
|---|---|---|---|---|---|---|
| Market cap | 4.78B | 6.32B | 2.56B | 1.74B | 3.12B | 40.23B |
| P/E (TTM) | 93.9 | 127.0 | — | 6.6 | — | 6.1 |
| Forward P/E | -439.6 | 25.9 | 42.9 | -12.5 | -7.9 | 46.7 |
| Price/book | 6.9 | 6.6 | 3.8 | 1.8 | 2.9 | 3.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −14.40% | +64.68% | +69.54% | +107.31% | +5.63% | −19.94% |
| Today | +5.71% | +0.83% | +5.54% | −38.23% | +3.29% | +1.49% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All TLX.AX news ›SHL Telemedicine to Fully Acquire Remaining Stakes in Israeli Subsidiaries After Court Ruling
Shl Telemedicine ( (CH:SHLTN) ) just unveiled an announcement. More about Shl Telemedicine Average Trading Volume: 18,990 Current Market Cap: CHF39.65M For an in-depth examination of SHLTN stock, go to TipRanks’ Overview page.
Telenor Denmark Advances Digital Security as Service Revenue Grows 4% in Q3
Telenor Denmark increases service revenue by 4.0% in the third quarter. At the same time, a new survey shows increasing customer satisfaction in Telenor, while CBB maintains its Nordic number one position among the named mobile companies.…
Sectra signs telepathology agreement with Diagnexia
Medical technology and cybersecurity company Sectra has signed an agreement with British pathology services provider Diagnexia for the digital management and sharing of pathology cases within the NHS.... Advanced Medical Equipment &…
Pro Medicus vs Telix Pharmaceuticals: Which is more likely to double your money in 2 years?
Can Pro Medicus or Telix Pharmaceuticals double your money on the ASX? We stack up their value, growth, and price momentum for 2026. Laura Stewart is a Finance Editor at The Motley Fool, where she covers Australian and international equity…
Polyrizon enrolls first patient in U.S. study of NASARIX
Polyrizon (PLRZ) announced the enrollment of the first patient in its U.S. clinical study to evaluate NASARIX, the Company’s investigational All... Polyrizon enrolls first patient in U.S. study of NASARIX Polyrizon (PLRZ) announced the…
Teladoc Health Reports Third Quarter 2026 Results
Oracle Investor Day 2026: Accelerating Value Creation Elong Power Holding Limited (NASDAQ: ELPW) Announces Subsidiary’s Entry into a US$25.5 Million Annual Cooperation Agreement, Marking a Critical Step Forward in Its Global Distribution…
More from 1 other outlet
Syndax to Announce Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 2, 2026
NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innova... NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a…
Buy, hold, sell: Telix Pharmaceuticals, BHP, CBA shares
James Bills from Shaw and Partners shares his views and ratings on 3 ASX stocks. ASX shares and ETFs News writing Macroeconomic trends Real estate Diploma in Journalism, Macleay College "Don't look for the needle in the haystack. Just buy…
Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
Following FDA feedback, and subject to the nature of that feedback, Medicus’ intent is to seek to out-license or otherwise strategically partner the Teverelix APC program rather than independently fund execution of the proposed…
Telix Pharmaceuticals: The ITM Deal Could Strengthen The Long-Term Buy Case
Telix Pharmaceuticals maintains a Buy rating, driven by robust 3Q26 performance and the strategic ITM acquisition. Read more on TLX stock here. - Telix Pharmaceuticals maintains a buy rating, driven by robust 3Q26 performance and the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- newsfilecorp.com27
- marketscreener.com9
- kalkinemedia.com6
- fool.com.au5
- markets.businessinsider.com5
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 99 articles, not a forecast.